Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/1b Study of TRU-016 in Patients With Previously Treated Chronic Lymphocytic Leukemia or Select Subtypes of Non-Hodgkin's Lymphoma

NCT00614042 is registered in ClinicalTrials.gov with Aptevo Therapeutics as lead sponsor.

NCT NCT00614042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00614042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/1b Study of TRU-016 in Patients With Previously Treated Chronic Lymphocytic Leukemia or Select Subtypes of Non-Hodgkin's Lymphoma
Lead sponsor
Aptevo Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2008
Completion date
March 31, 2012
Enrollment
96 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia (cll), non-hodgkin's lymphoma (nhl)